Patent Assignment
Reel/Frame 070514/0302
Change of Name
Recorded: 2025-03-13
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Property
(1)
Salts and Esters of APX3330 and Therapeutic Uses Thereof
PCT:
PCT/US2023/074113 ↗
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 7, 2024
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067655/0821 →
Assignment of Assignor's Interest
Jun 7, 2024
From: LUNGAN, MARIA-ANDREEA; PATRASCU, ANDREI-ALUNEL; MANTA, CORINA-MIHAELA
To: SARA PHARM SOLUTIONS S.R.L.
Reel/Frame 067655/0981 →
Assignment of Assignor's Interest
Jun 7, 2024
From: SARA PHARM SOLUTIONS S.R.L.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067656/0199 →
Assignment of Assignor's Interest
Jun 7, 2024
From: CARESTIA, ANTHONY; HOUSLEY, JON
To: CAMBREX HIGH POINT, INC.
Reel/Frame 067656/0848 →
Assignment of Assignor's Interest
Jun 7, 2024
From: CAMBREX HIGH POINT, INC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067657/0131 →